Laurus Labs Ltd. benchmarking: Perfomance to industry peers

Financial

	Laurus Labs	Neuland Laboratories	Acutaas Chemicals
Operational Metrics
Pharmaceuticals
Fermentation Capacity	250.0 KL	n/a	n/a
Number of ANDA's Filed in Europe	22.0	n/a	n/a
Number of ANDA's Approved in Europe	19.0	n/a	n/a
Number of ANDA's Filed in Canada	23.0	n/a	n/a
Number of ANDA's Approved by Canada	16.0	n/a	n/a
Number of ANDA's Filed in USA	45.0 .	n/a	n/a
Number of ANDA's Approved By USFDA	36.0 .	n/a	n/a
US DMF Filings	91.0 .	73.0 .	n/a
R&D as a % of Total Sales	4.6 %	4.15 %	n/a
Financials
5 yr Average ROE	18.77 %	14.95 %	15.72 %
5yr average Equity Multiplier	2.06	1.56	1.57
5yr Average Asset Turnover Ratio	0.71	0.74	0.74
5yr Avg Net Profit Margin	11.95 %	13.18 %	12.98 %
Price to Book	11.48	13.2	9.64
P/E	80.62	89.07	60.84
5yr Avg Cash Conversion Cycle	91.73 Days	38.21 Days	55.02 Days
Inventory Days	114.71 Days	87.5 Days	64.12 Days
Days Receivable	120.6 Days	85.17 Days	90.06 Days
Days Payable	145.16 Days	118.14 Days	127.33 Days
5yr Average Interest Coverage Ratio	8.98	20.78	25.42
5yr Avg ROCE	22.73 %	17.63 %	20.01 %
5yr Avg Operating Profit Margin	24.36 %	21.01 %	20.92 %
5 yr average Debt to Equity	0.56	0.15	0.23
5yr CAGR Net Profit	-18.29 %	26.4 %	24.06 %
5yr Average Return on Assets	8.99 %	9.87 %	9.8 %
Shareholdings
Promoter Holding	27.59 %	32.64 %	32.66 %
Share Pledged by Promoters	2.69 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.32 %	-3.58 %	-6.75 %
Change in Mutual Fund Holding (3 Yrs)	3.03 %	8.99 %	12.5 %

	Laurus Labs	Neuland Laboratories	Acutaas Chemicals
Product Wise Break-Up	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 37.0 Formulations 32.0 Synthesis 28.0 Bio 3.0 Ingredients 0 Generic Drug Substances(GDS) 0 Custom Manufacturing Solutions(CMS) 0 Specialty Chemicals 0 Pharma Intermediates 0	Product Wise Break-Up Formulations 0 Formulations 71.0 Pharma Intermediates 0 Specialty Chemicals 0 Active Pharmaceutical Ingredient (API) 0 Ingredients 0 Synthesis 0 Bio 0 Custom Manufacturing Solutions(CMS) 26.0 Others 3.0	Product Wise Break-Up Formulations 0 Generic Drug Substances(GDS) 0 Pharma Intermediates 85.76 Specialty Chemicals 14.24 Active Pharmaceutical Ingredient (API) 0 Ingredients 0 Synthesis 0 Bio 0 Custom Manufacturing Solutions(CMS) 0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 55.0 Europe 25.0 North America 20.0 India 0 USA 0 Germany 0 Spain 0 Israel 0 France 0 China 0 Finland 0 Italy 0	Location Wise Break-Up Israel 0 Germany 0 Italy 0 USA 29.35 North America 0 Spain 0 France 0 Europe 29.86 Rest of the World 10.4 Finland 0 China 0 India 30.39	Location Wise Break-Up Israel 1.9 Germany 3.4 Italy 14.2 USA 0 North America 0 Spain 2.5 France 0 Europe 0 Rest of the World 0 Finland 18.6 China 3.9 India 44.0 Others 11.5